Skip to main content
logo
Valneva SE (VALN)
NASDAQ: VALN · Real-Time Price · USD
5.39
+0.03 (0.56%)
Jun 15, 2026, 4:00 PM EDT - Market closed

Revenue by Segment

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Development and Commercialization of Prophylactic Vaccines
174.66M169.58M153.71M361.30M348.09M
Development and Commercialization of Prophylactic Vaccines Growth
3.00%10.32%-57.46%3.80%-
Total
174.66M169.58M153.71M361.30M348.09M
Total Growth
3.00%10.32%-57.46%3.80%215.52%

Revenue by Geography

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
United States
53.61M48.59M32.96M-23.80M40.34M
United States Growth
10.32%47.41%--10.78%
Canada
30.13M32.32M28.19M18.90M4.23M
Canada Growth
-6.79%14.64%49.14%347.33%-52.86%
Germany
17.47M18.37M13.50M68.53M726.00K
Germany Growth
-4.93%36.07%-80.30%9339.26%-89.72%
France
14.67M7.22M5.87M46.61M1.00M
France Growth
103.16%23.08%-87.41%4560.80%36.24%
Nordics
13.90M13.94M12.70M12.04M2.44M
Nordics Growth
-0.28%9.78%5.41%394.38%-15.00%
Other Europe
13.88M9.06M9.34M18.74M2.08M
Other Europe Growth
53.24%-2.99%-50.19%803.13%55.55%
United Kingdom
12.64M19.49M20.27M181.13M2.71M
United Kingdom Growth
-35.12%-3.83%-88.81%6591.13%46.56%
Austria
9.47M15.90M14.58M21.79M9.34M
Austria Growth
-40.41%9.01%-33.08%133.30%180.26%
Rest Of World
8.90M4.69M16.31M17.36M134.00K
Rest Of World Growth
89.66%-71.23%-6.06%12855.22%-96.04%
Total
174.66M169.58M153.71M361.30M62.98M
Total Growth
3.00%10.32%-57.46%473.64%-4.48%